期刊文献+

TGM1基因过表达可抑制乳腺癌细胞的上皮-间质转化 被引量:1

Overexpression of TGM1 gene inhibits epithelial-mesenchymal transition in breast cancer cells
原文传递
导出
摘要 目的 :探究转谷氨酰胺酶1(transglutaminase 1,TGM1)基因过表达对乳腺癌细胞上皮-间质转化(epithelial-mesenchymal transition,EMT)的影响。方法 :采用实时荧光定量PCR法检测鼠源性乳腺癌FE1.2和FE1.3细胞中TGM1 m RNA的表达水平。采用脂质体法将携带有TGM1基因全长序列的重组载体质粒p CMV3-TGM1-GFPspark转染至FE1.2细胞中,构建TGM1基因过表达的FE1.2细胞株(FE1.2-TGM1)。光学显微镜下观察FE1.2细胞形态的变化,FCM法测量细胞粒径的大小;MTT法检测TGM1基因过表达对鼠乳腺癌细胞增殖能力的影响;实时荧光定量PCR法和蛋白质印迹法分别检测EMT相关分子标志物上皮型钙黏蛋白(E-cadherin)、波形蛋白(vimentin)、β-链蛋白(β-catenin)以及细胞周期调节蛋白D1(cyclin D1)m RNA和蛋白的表达水平。最后,采用细胞划痕愈合实验检测TGM1过表达对细胞迁移能力的影响。结果 :FE1.3细胞中TGM1 m RNA的表达水平明显高于FE1.2细胞(P<0.001)。将重组载体p CMV3-TGM1-GFPspark转入FE1.2细胞后,FE1.2细胞中TGM1 m RNA和蛋白的表达水平明显上调(P<0.001和P<0.01),细胞形态发生明显改变,细胞的粒径增大(P<0.01),而FE1.2细胞的增殖能力明显降低(P<0.001)。TGM1基因过表达的E1.2细胞中E-cadherin m RNA的表达水平明显上调(P<0.01),vimentin m RNA及蛋白的表达水平均明显下调(P值均<0.001),cyclin D1 m RNA的表达水平明显上调(P<0.05),而cyclin D1蛋白表达水平无明显变化(P>0.05),β-catenin m RNA的表达水平无明显变化(P>0.05),β-catenin蛋白的表达水平明显下调(P<0.01);TGM1过表达后FE1.2细胞的迁移能力明显减弱(P<0.05)。结论 :TGM1基因过表达能抑制乳腺癌细胞的EMT。 Objective: To investigate the effect of transglutaminase 1(TGM 1) gene overexpression on the epithelial-mesenchymal transition(EMT) in breast cancer cells.Methods: The expression level of TGM1 m RNA in rat breast cancer FE1.2 and FE1.3 cells was detected by real-time fluorescent quantitative PCR. The recombinant vector p CMV3-TGM1-GFPspark was transfected into FE1.2 cells by liposome method to construct the TGM1 gene overexpressed FE1.2 cell strain. The morphological change of FE1.2 cells after transfection with p CMV3-TGM1-GFPspark was observed under an optical microscope, the cell size was detected by FCM method. The effect of TGM 1 gene overexpression on the proliferation of FE1.2 cells was examined by MTT method. The expression levels of EMT molecular markers E-cadherin, vimentin, β-catenin, cyclin D1 m RNAs and proteins were examined by real-time fluorescent quantitative PCR and Western blotting, respectively. Finally, the migration ability of FE1.2 cells transfected with p CMV3-TGM1-GFPspark was detected by wound healing assay.Results: The expression level of TGM1 m RNA in FE1.3 cells was significantly higher than that in FE1.2 cells(P〈0.001). After the recombinant vector p CMV3-TGM1-GFPspark was transfected into FE1.2 cells, the expression levels of TGM1 m RNA and protein were significantly up-regulated(both P〈0.001); the shape of FE1.2 cells was changed, and the diameter of FE1.2 cells was enlarged(P〈0.01). As compared with the FE1.2 cells(blank control) and FE1.2-vector group, the proliferation ability of FE1.2 cells transfected with p CMV3-TGM1-GFPspark was significantly inhibited(both P〈0.001), the m RNA level of E-cadherin was up-regulated(P〈0.01), the expression levels of vimentin m RNA and protein and β-catenin protein were down-regulated(all P〈0.01), the expression level of cyclin D1 m RNA was up-regulated(P〈0.05), the expression levels of cyclin D1 protein and β-catenin m RNA were not significantly changed(both P〈0.05). The migration ability of FE1.2 cells after TGM1 gene overexpression was significantly inhibited(P〈0.05).Conclusion: Overexpression of TGM 1 gene can inhibit EMT in breast cancer cells.
作者 宋喻 姚尧 夏雷 肖潇 刘务玲 杨珏 刘唐婧君 宋晶睿 宋佳蕾 王宁 刘杰麟 YAACOV Ben-David SONG Yu;YAO Yao;XlA Lei;XlAO Xiao;LIU Wuling;YANG Jue;LIU-TANG Jingjun;SONG Jingrui;SONG Jialei;WANG Ning;LIU Jielin;YAACOV Ben-David(Department of Immunology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550025,Guizhou Province,China;Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences,Guiyang 550014,Guizhou Province,China;State Key Laboratory for Functions and Applications of Medicinal Plants,Guizhou Medical University,Guiyang 550025,Guizhou Province,China;Department of Pharmacology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550025,Guizhou Province,China;College of Bioengineering and Faculty of Sciences,Chongqing University,Chongqing 400044,China)
出处 《肿瘤》 CAS CSCD 北大核心 2018年第7期670-679,共10页 Tumor
基金 国家自然科学基金资助项目(编号:81472609) 贵州省科技合作计划资助项目[编号:黔科合LH字(2015)7403]
关键词 乳腺肿瘤 基因 肿瘤抑制 转谷氨酰胺酶1 上皮-间质转化 Breast neoplasm Tumor suppressor Transglutaminase 1 Epithelial-mesenchymal transition
  • 相关文献

参考文献8

二级参考文献137

  • 1魏生才,郑广勇,张锡宝,黄振明,邓俐,张堂德.板层状鱼鳞病TGM1基因突变研究[J].中华皮肤科杂志,2006,39(3):131-133. 被引量:8
  • 2李永奖,张力成,杨国敬,王伟良,蔡春元.后方关节囊修补预防全髋关节置换术后早期脱位[J].中国矫形外科杂志,2006,14(12):891-894. 被引量:32
  • 3胡蕾,姜汉国.PI3K/AKT信号转导通路与肿瘤转移及其机制的研究进展[J].医学综述,2006,12(22):1375-1377. 被引量:18
  • 4姜影,佟丹丹,张颖.乳腺癌中RUNX3、cyclin D1和p27^(kip1)蛋白的表达及其意义[J].中国肿瘤,2007,16(6):442-444. 被引量:5
  • 5Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest ,2009 ,119; 1420-1428.
  • 6Bud a A,Pignatelli M. E-cadherin and the cytoskeletal network in colorectal cancer development and metastasis. Cell Commun Adhes,2011,18 ; 133-143.
  • 7Hao L, Ha JR, Kuzel P,et al. Cadherin switch from E-to N-cadherin in melanoma progression is regulated by the PI3K/ PTEN pathway through Twist and Snail. Br J Dermatol, 2012,166:1184~1197.
  • 8Lehembre F, Yilmaz M,Wicki A,et al. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J ,2008,27:2603-2615.
  • 9Nam EH,Lee Y, Park YK’et al. ZEB2 upregulates integrin a5 expression through cooperation with Spl to induce invasion during epithelial-mesenchymal transition of human cancer cells. Carcinogenesis,2012,33 ; 563-571.
  • 10Walsh LA, Nawshad A,Medici D. Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. Matrix Biol,2011,30:243-247.

共引文献44

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部